AI MARKET SCANNING

Krystal Biotech, Inc.

📅 Next Catalyst: Nov 02, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -3.40%
MAX GAP RECORD -14.04%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $KRYS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 02, 2026 Earnings Release 2026-11-02 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 03, 2026 Earnings Release 2026-08-03 (BEFORE OPEN)
-5.99%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+1.45%
Feb 17, 2026 Earnings Release 2026-02-17 (BEFORE OPEN)
+0.00%
Nov 03, 2025 Earnings Release 2025-11-03 (BEFORE OPEN)
+0.12%
Aug 04, 2025 Earnings Release 2025-08-04 (BEFORE OPEN)
-2.03%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-11.88%
Feb 19, 2025 Earnings Release 2025-02-19 (BEFORE OPEN)
-4.75%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.6%
Bullish Gaps (2)
Bearish Gaps (8)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $KRYS

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-23 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 4482m +4.91%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗